menu

BioInnovation Institute

Development and maturing of research projects

Research ideas often fail to progress into products and solutions because of the absence of suitable facilities, experienced personnel and access to finance. The Novo Nordisk Foundation wants to change this.

BioInnovation Institute (BII) is a large new center that will help innovative entrepreneurs and talented researchers develop research projects to the point at which they attract crucial capital investment.

The hope is that this will see new products and solutions that could in the future combat disease, improve health or conserve natural resources to benefit people and society around the world, which otherwise would never come to fruition.

BII is a Danish initiative with an international perspective. It will be located in Copenhagen to create synergy with the existing research environments and laboratory facilities in the life sciences.

The Foundation has awarded an initial grant of DKK 392 million to cover the 3-year establishment phase.

The centre will reaffirm Denmark as a powerhouse in northern Europe for start-ups and mature projects in the life sciences. We hope that it will help global investors see the life sciences in Denmark as an attractive investment opportunity, which would result in new companies and jobs in the long term.

 

The four phases

During the discovery phase, BII will attract talented researchers and entrepreneurs from Denmark and abroad from research environments at universities and hospitals to collaborate on new pioneering ideas and inventions across disciplines.

The transition phase will primarily test promising projects in an acceleration process in which excellent research ideas are further developed and business plans are drafted. Experts and mentors will be involved in this phase.

The incubation phase covers projects for which a start-up company has been established. These projects have significant potential to be further developed.

In the transition and incubation phases, BII will support start-up companies with risk capital and feedback through access to a network of experts within the start-up environment, financing, legal affairs and other areas critical for the business models of start-ups so that they develop towards becoming financially sustainable. Start-up companies that can attract external funding to implement the ideas in specific solutions then leave the incubation phase.

The growth phase covers companies that have attracted funding from external investors. They can use BII’s facilities on market terms.

 

The 3-year establishment phase

The 3-year establishment phase will focus on building the transition and incubationphases. This will enable existing research in the life sciences to benefit quickly from the opportunities offered by BII. During this period, BII will be anchored in the Foundation.

After the establishment phase is evaluated, the Foundation’s Board of Directors will decide whether to establish BII as an independent foundation for years 4–10. When this happens, all activities and results from the first 3 years of operating BII will be available to the new foundation. This enables the first 3 years to be used to build a solid framework to ensure that BII starts well.

392
In 2017, the Novo Nordisk Foundation awarded DKK 392 million over 3 years to establish the BioInnovation Institute.
Link
Visit the BioInnovation Institute
Additional information

Mikkel Skovborg,
Senior Officer
Novo Nordisk Foundatio
mswv@novo.dk

Application Info
The Novo Nordisk Foundation decides whether to award stand-alone grants for individual projects based on the applications received.

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close